SAMPLE_NAME	GENE	TYPE	SAMPLE_IMPACT	DB_IMPACT	DB_DRIVER_FREQUENCY	DB_MUTATION_FREQUENCY	CANCER_CENSUS	GDSC_DRUGS
TCGA-02-0003-01A	CDK4	AMPL	69.635	0.000	0.000	0.016	Y	SB 216763[http://www.cancerrxgene.org/translation/Drug/1025],Vorinostat[http://www.cancerrxgene.org/translation/Drug/1012]
TCGA-02-0003-01A	TP53	MUT	69.635	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]
TCGA-02-0003-01A	GLI1	AMPL	69.635	76.623	0.024	0.032	N	N/A
TCGA-02-0033-01A	PIK3CA	MUT	65.461	742.320	0.264	0.264	Y	AZD6482[http://www.cancerrxgene.org/translation/Drug/156],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171],PAC-1[http://www.cancerrxgene.org/translation/Drug/175],Pazopanib[http://www.cancerrxgene.org/translation/Drug/199],GW 441756[http://www.cancerrxgene.org/translation/Drug/1023],SB 216763[http://www.cancerrxgene.org/translation/Drug/1025]
TCGA-02-0033-01A	RB1	MUT	65.461	652.368	0.224	0.224	Y	PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047]
TCGA-02-0033-01A	TP53	MUT	65.461	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]
TCGA-02-0047-01A	CREBBP	MUT	52.807	387.435	0.160	0.176	Y	N/A
TCGA-02-0047-01A	PIK3CA	MUT	52.807	742.320	0.264	0.264	Y	AZD6482[http://www.cancerrxgene.org/translation/Drug/156],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171],PAC-1[http://www.cancerrxgene.org/translation/Drug/175],Pazopanib[http://www.cancerrxgene.org/translation/Drug/199],GW 441756[http://www.cancerrxgene.org/translation/Drug/1023],SB 216763[http://www.cancerrxgene.org/translation/Drug/1025]
TCGA-02-0047-01A	CELSR1	MUT	1.419	1.420	0.016	0.080	N	N/A
TCGA-02-2470-01A	CAPN1	MUT	117.302	0.000	0.000	0.024	N	N/A
TCGA-02-2470-01A	IFNA1	DEL	117.302	0.000	0.000	0.152	N	N/A
TCGA-02-2470-01A	CDKN2A	DEL	117.302	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]
TCGA-02-2470-01A	CNTNAP2	MUT	26.386	1.571	0.016	0.088	N	N/A
TCGA-02-2470-01A	NFIX	MUT	10.067	0.000	0.000	0.016	N	N/A
TCGA-02-2470-01A	RBBP5	AMPL	7.993	0.000	0.000	0.048	N	N/A
TCGA-02-2483-01A	FGFR2	AMPL	43.889	0.000	0.000	0.032	Y	PD-173074[http://www.cancerrxgene.org/translation/Drug/1049],A-443654[http://www.cancerrxgene.org/translation/Drug/86]
TCGA-02-2483-01A	TP53	MUT	43.889	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]
TCGA-02-2485-01A	GLI1	AMPL	38.402	76.623	0.024	0.032	N	N/A
TCGA-02-2485-01A	TP53	MUT	38.402	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]
TCGA-02-2486-01A	ATR	MUT	134.882	0.000	0.000	0.040	Y	N/A
TCGA-02-2486-01A	CDKN2A	DEL	134.882	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]
TCGA-02-2486-01A	IFNA1	DEL	134.882	0.000	0.000	0.152	N	N/A
TCGA-06-0122-01A	CYP19A1	MUT	92.880	0.000	0.000	0.000	N	N/A
TCGA-06-0122-01A	EGFR	AMPL	11.879	352.698	0.112	0.112	Y	BIBW2992[http://www.cancerrxgene.org/translation/Drug/1032],Bosutinib[http://www.cancerrxgene.org/translation/Drug/1019]
TCGA-06-0122-01A	LRP1	MUT	11.879	0.000	0.000	0.096	N	N/A
TCGA-06-0122-01A	APH1A	MUT	2.490	0.000	0.000	0.120	N	N/A
TCGA-06-0122-01A	TTN	MUT	2.200	1662.774	0.624	0.624	N	N/A
TCGA-06-0122-01A	TNKS	AMPL	2.183	3.234	0.072	0.104	N	N/A
TCGA-06-0122-01A	CDKN2A	DEL	1.533	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]
TCGA-06-0124-01A	NCAN	MUT	71.387	0.000	0.000	0.048	N	N/A
TCGA-06-0124-01A	VCAN	MUT	61.809	0.000	0.000	0.080	N	N/A
TCGA-06-0124-01A	EGFR	AMPL	58.325	352.698	0.112	0.112	Y	BIBW2992[http://www.cancerrxgene.org/translation/Drug/1032],Bosutinib[http://www.cancerrxgene.org/translation/Drug/1019]
TCGA-06-0124-01A	SMARCA2	MUT	58.325	0.424	0.016	0.128	N	N/A
TCGA-06-0124-01A	IFNA1	DEL	58.325	0.000	0.000	0.152	N	N/A
TCGA-06-0124-01A	KLHL9	DEL	3.270	24.136	0.120	0.168	N	N/A
TCGA-06-0124-01A	CDKN2A	DEL	1.938	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]
TCGA-06-0124-01A	EBF2	MUT	1.125	0.124	0.016	0.056	N	N/A
